Work

Supplementary Figures S1-6 from Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts

Year: 2023

Type: supplementary-materials

Abstract: Supplementary figure S1: Survival analysis (Kaplan-Meier estimates) with Breast cancer specific survival (BCSS) as end point for All patients of Cohort 1. Supplementary figure S2: Flowchart showing simplified results from Cohort 1. Supplementary figure S3: Additional prognostic value of gene expression signatures beyond Ki67/IHC, Cohort 1. Supplementary figure S4: Additional prognostic value of Ki67/IHC beyond gene expression signatures, Cohort 1. Supplementary figure S5: Additional prognostic value of gene expression signatures beyond Ki67/IHC, Cohort 2. Supplementary figure S6: Additional prognostic value of Ki67/IHC beyond gene expression signatures, Cohort 2.

DOI: 10.1158/1078-0432.22462326.v1

Authors: Arian Lundberg, Linda S. Lindström, J. Chuck Harrell, Claudette Falato, Joseph W. Carlson, Paul K. Wright, Theodoros Foukakis, Charles M. Perou, Kamila Czene, Jonas Bergh, Nicholas P. Tobin

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361920819

Cites:

Cited by:

Related to: 10